Work

Arterial Thrombus in a Heart Transplant Recipient

Year: 2016

Type: article

Abstract: The patient was a 51-year-old woman who was diagnosed with non-Hodgkin’s lymphoma at age 46, achieved remission after Adriamycin-based chemotherapy, but developed severe Adriamycin-induced cardiomyopathy. She was implanted with a left ventricular assist device at age 49, and underwent an orthotopic heart transplant 9 months prior to this presentation. At the time of transplant, she received induction therapy with antithymocyte globulin (total dose 4 mg/kg) and was started on maintenance therapy with tacrolimus (target level 10–13 mg/dL), mycophenolate mofetil (1500 mg BID), and prednisone.

Source: American Journal of Transplantation

DOI: 10.1111/ajt.14071

Authors: J.A. Hess, K.E. Hanson, C.H. Selzman, J. Stehlik

Institution: University of Utah

Language: English

Topic: Transplantation: Methods and Outcomes

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,300